Expect to See More Patients Switch From a Biologic to a Biosimilar

More questions will come up about biosimilars...now that BC will require patients to switch to biosimilars to save healthcare dollars.

Biosimilars are biologics that are highly SIMILAR to the original, or "reference," biologic...but cost up to 50% less.

For example, patients in BC who take Lantus for diabetes may switch to the biosimilar Basaglar. Both contain insulin glargine...but Basaglar is about $15/pen versus $20/pen for Lantus.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote